NTPM’s FY14 results were below consensus but well within our estimates. Sales and earnings were higher, mainly buoyed by stronger sales across the board. The company proposed a final dividend of 1.45 sen. Maintain NEUTRAL, with an unchanged FV of MYR0.82.
-
FY14 results were within our estimates. NTPM’s FY14 turnover and net profit increased by 6.9% and 9.7% y-o-y respectively, backed by astellar performance from its personal care segment. Revenue from its personal care products division improved by 19.3% y-o-y, largely driven by higher sales of baby diapers. Meanwhile paper product sales rose slightly by 2.3% due to higher demand for tissue products in the export market. The stronger FY14 net profit was boosted by better PBT growth from the company’s paper products (+0.1% y-o-y) and personal care (+20.5% y-o-y) segments. Vis-à-vis 4Q13, 4Q14’s revenue grew 7.6% while net profit declined by 8.8% due to higher operating expenses.
-
Margins declined. Its FY14 EBIT and PBT margins eroded by 60bps and 40bps y-o-y respectively, mainly due to an increase in overhead costs after the electricity tariff increase took effect in January. On asegmental basis, the stronger PBT margin from the personal care segment (8.6% from 8.5% in FY13) was offset by the weaker margin from paper products (14.7% from 15% in FY13). A final single-tier DPS of 1.45 sen was declared this quarter, which took its FY14 DPS to 2.9 sen – in line with our forecasts.
-
Key risks. The key risks include volatile raw material prices and weaker demand. We are leaving our forecasts untouched for now, as the numbers were within our expectation.
-
Maintain NEUTRAL. We maintain our NEUTRAL rating, with an unchanged FV of MYR0.82, based on a 15.5x P/E on FY15 EPS. The target P/E is at a 15% discount to the 18.3x weighted average P/E of its regional peers. We believe the stock is fairly valued at the moment as it is trading on par with its regional peers.
Source: RHB